Plasmacytoid dendritic cells promote HIV-1-induced group 3 innate lymphoid cell depletion

Journal of Clinical Investigation

Volumn 125, Issue 9, 2015, Pages 3692-3703

  Zhang, Zheng ^a,b   Cheng, Liang ^b   Zhao, Juanjuan ^a,c   Li, Guangming ^b   Zhang, Liguo ^c   Chen, Weiwei ^a   Nie, Weiming ^a   Blanco, J Reszka Natalia ^b   Wang, Fu Sheng ^a   Su, Lishan ^b,c  

^a BEIJING 302 HOSPITAL   (China)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF BIOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD3 ANTIGEN; CD45 ANTIGEN; FAS ANTIGEN; FAS LIGAND; INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 7 RECEPTOR; STEM CELL FACTOR RECEPTOR; FASL PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL THERAPY; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHOID CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; TH17 CELL; VIRUS LOAD; ANIMAL; DENDRITIC CELL; DISEASE MODEL; FEMALE; IMMUNOLOGY; LYMPHOCYTE DEPLETION; MALE; PATHOLOGY; PLASMA CELL;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; FEMALE; HIV-1; HUMANS; INTERFERON TYPE I; LYMPHOCYTE DEPLETION; MALE; MICE; PLASMA CELLS;

EID: 84941702583     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI82124     Document Type: Article

References (57)

1. Spits H, Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol. 2012;30:647-675.
2. Spits H, et al. Innate lymphoid cells-A proposal for uniform nomenclature. Nat Rev Immunol. 2013;13(2):145-149.
3. Sonnenberg GF, Mjosberg J, Spits H, Artis D. SnapShot: innate lymphoid cells. Immunity. 2013;39(3):622-622.
4. Bernink JH, et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol. 2013;14(3):221-229.
5. Mjosberg JM, et al. Human IL-25-And IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 CD161. Nat Immunol. 2011;12(11):1055-1062.
6. Hazenberg MD, Spits H. Human innate lymphoid cells. Blood. 2014;124(5):700-709.
7. Cella M, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009;457(7230):722-725.
8. Moro K, et al. Innate production of T(H)2 cytokines by adipose tissue-Associated c-Kit(+)Sca-1(+) lymphoid cells. Nature. 2010;463(7280):540-544.
9. Scandella E, et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat Immunol. 2008;9(6):667-675.
10. Monticelli LA, et al. Innate lymphoid cells promote lung-Tissue homeostasis after infection with influenza virus. Nat Immunol. 2011;12(11):1045-1054.
11. Sonnenberg GF, et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science. 2012;336(6086):1321-1325.
12. Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol. 2011;12(5):383-390.
13. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol. 2011;12(1):21-27.
14. Hepworth MR, Sonnenberg GF. Regulation of the adaptive immune system by innate lymphoid cells. Curr Opin Immunol. 2014;27:75-82.
15. Dyring-Andersen B, et al. Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. Br J Dermatol. 2014;170(3):609-616.
16. Teunissen MB, et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin blood of psoriasis patients. J Invest Dermatol. 2014;134(9):2351-2360.
17. Magri G, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15(4):354-364.
18. Crellin NK, Trifari S, Kaplan CD, Satoh-Takayama N, Di Santo JP, Spits H. Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity. 2010;33(5):752-764.
19. Cella M, Otero K, Colonna M. Expansion of human NK-22 cells with IL-7, IL-2, IL-1β reveals intrinsic functional plasticity. Proc Natl Acad Sci U S A. 2010;107(24):10961-10966.
20. Hepworth MR, et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature. 2013;498(7452):113-117.
21. Xu H, Wang X, Liu DX, Moroney-Rasmussen T, Lackner AA, Veazey RS. IL-17-producing innate lymphoid cells are restricted to mucosal tissues are depleted in SIV-infected macaques. Mucosal Immunol. 2012;5(6):658-669.
22. Li H, et al. Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infection. PLoS Pathog. 2014;10(12):e1004551.
23. Kloverpris HN, et al. Innate lymphoid cells are depleted in HIV infection. AIDS Res Hum Retroviruses. 2014;30(suppl 1):A14.
24. Raffatellu M, et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med. 2008;14(4):421-428.
25. Reeves RK, et al. Gut inflammation and indoleamine deoxygenase inhibit IL-17 production promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection. Blood. 2011;118(12):3321-3330.
26. Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL. Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol. 2012;12(11):786-798.
27. Zhang L, Su L. HIV-1 immunopathogenesis in humanized mouse models. Cell Mol Immunol. 2012;9(3):237-244.
28. Li G, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10(7):e1004291.
29. Nixon CC, et al. HIV-1 infection of hematopoietic progenitor cells in vivo in humanized mice. Blood. 2013;122(13):2195-2204.
30. Zhang L, Jiang Q, Li G, Jeffrey J, Kovalev GI, Su L. Efficient infection, activation, and impairment of pDCs in the BM and peripheral lymphoid organs during early HIV-1 infection in humanized rag2(-)/(-)γ C(-)/(-) mice in vivo. Blood. 2011;117(23):6184-6192.
31. Zhang L, Kovalev GI, Su L. HIV-1 infection pathogenesis in a novel humanized mouse model. Blood. 2007;109(7):2978-2981.
32. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes consequences. J Pathol. 2008;214(2):231-241.
33. Sandler NG, et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature. 2014;511(7511):601-605.
34. Teijaro JR, et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science. 2013;340(6129):207-211.
35. Wilson EB, et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science. 2013;340(6129):202-207.
36. Papatriantafyllou M. Infection: The interferon paradox. Nat Rev Immunol. 2013;13(6):392.
37. Sivaraman V, Zhang L, Meissner EG, Jeffrey JL, Su L. The heptad repeat 2 domain is a major determinant for enhanced human immunodeficiency virus type 1 (HIV-1) fusion pathogenicity of a highly pathogenic HIV-1 Env. J Virol. 2009;83(22):11715-11725.
38. Fraietta JA, et al. Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection. PLoS Pathog. 2013;9(10):e1003658.
39. Kim CJ, et al. A role for mucosal IL-22 production Th22 cells in HIV-Associated mucosal immunopathogenesis. Mucosal Immunol. 2012;5(6):670-680.
40. Klatt NR, et al. Loss of mucosal CD103+ DCs IL-17+ IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. 2012;5(6):646-657.
41. Jiang Q, et al. FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-γC-/-mice in vivo. Blood. 2008;112(7):2858-2868.
42. Takatori H, et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med. 2009;206(1):35-41.
43. Cupedo T, et al. Human fetal lymphoid tissueinducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol. 2009;10(1):66-74.
44. Zhao J, et al. Pathological functions of interleukin-22 in chronic liver inflammation fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment. Hepatology. 2014;59(4):1331-1342.
45. Fernandes SM, et al. Enteric mucosa integrity in the presence of a preserved innate interleukin 22 compartment in HIV type 1-Treated individuals. J Infect Dis. 2014;210(4):630-640.
46. Brenchley JM, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12(12):1365-1371.
47. Favre D, et al. Tryptophan catabolism by indoleamine 2, 3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med. 2010;2(32):32ra36.
48. Estes JD. Pathobiology of HIV/SIV-Associated changes in secondary lymphoid tissues. Immunol Rev. 2013;254(1):65-77.
49. Sun L, et al. Type I interferons link viral infection to enhanced epithelial turnover and repair. Cell Host Microbe. 2015;17(1):85-97.
50. Poonia B, Pauza CD, Salvato MS. Role of the Fas/FasL pathway in HIV or SIV disease. Retrovirology. 2009;6:91.
51. Mandl JN, et al. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med. 2008;14(10):1077-1087.
52. Beignon AS, et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest. 2005;115(11):3265-3275.
53. Hosmalin A, Lebon P. Type I interferon production in HIV-infected patients. J Leukoc Biol. 2006;80(5):984-993.
54. Grossman Z, Meier-Schellersheim M, Sousa AE, Victorino RM, Paul WE. CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause? Nat Med. 2002;8(4):319-323.
55. Mortha A, et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science. 2014;343(6178):1249288.
56. van de Pavert SA, et al. Maternal retinoids control type 3 innate lymphoid cells set the offspring immunity. Nature. 2014;508(7494):123-127.
57. Zhang Z, et al. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology. 2008;134(7):1938-1949.